Infection After Solid Organ Transplantation: An Absolute Success and Still a Relative Problem

1. Pinner RW Teutsch SM Simonsen L , et al. Trends in infectious diseases mortality in the United States. JAMA 1996;275:189–93

2. Paya CV. Fungal infections in solid organ transplantation. Clin Inf Dis 1993;16:677–88

3. Pfaller MA. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Inf Dis 1996;22(Suppl 2):S89–94

4. Johnson EM Wamock DW Luker J , et al. Emergence of azole resistant in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidiasis. J Antimicrob Chemother 1995;35:103–14

5. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Inf Dis 1996;23:608–15

6. Andriole VT. Aspergillus infections: problems in diagnosis and treatment. Infect Agents Dis 1996;5:47–54

7. Georgopapadakou N Walsh TJ. Antifungal therapy: chemotherapeutic targets and immunologic strategies. Antimicrob Agents Chemother 1996;40:279–91

8. Bodey GP Anaisssie E Gutterman J Vadhan-Raj S. Role of granulocyte-macrophage colony stimulating factor as adjuvant therapy for fungal infection in patients with cancer. Clin Inf Dis 1993;17:705–7

9. Nagai H Guo J Choi H Kurup V. Inteferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis. J Inf Dis 1995;172:1554–60

10. Zamora MR Fullerton DA Campbell DN , et al. Use of cytomegalovirus hyperimmune globulin for prevention of CMV disease in CMV seropositive lung transplant recipients. Transplant Proc 1994;26(Suppl 1):49–51

11. Snydman DR Werner BG Dougherty NN , et al. Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. The Boston Center for Liver Transplantation CMVIG Study Group Ann Intern Med 1993;119:984–91

12. Plotkin SA Higgins H Kurtz JB , et al. Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients. Transplantation 1994;11:1176–8

13. Grellier L Mutimer D Ahmen M , et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996;348:1212–5

14. Bizzolon T Ducerf C Trepo C. New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin. J Hepatol 1995;23(Suppl 2):22–5

15. Shlaes DM Binczewski B Rice LB. Emerging antimicrobial resistance and the immunocompromised host. Clin Inf Dis 1993;17(Suppl 2):S527–36

16. Michaels MG Mcmichael JP Braky K , et al. Screening donors for xenotransplantation. The potential for xenozoonoses. Transplantation 1994;57:1462–5

17. Rao AS Fontes P Dodson F , et al. Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. Transplant Proc 1996;28:2959–65

18. Rastellini C Lu L Ricordi C , et al. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet cell allograft survival. Transplantation 1995;60:1366–70